Influenza: old and new threats
- PMID: 15577936
- DOI: 10.1038/nm1141
Influenza: old and new threats
Abstract
Influenza remains an important disease in humans and animals. In contrast to measles, smallpox and poliomyelitis, influenza is caused by viruses that undergo continuous antigenic change and that possess an animal reservoir. Thus, new epidemics and pandemics are likely to occur in the future, and eradication of the disease will be difficult to achieve. Although it is not clear whether a new pandemic is imminent, it would be prudent to take into account the lessons we have learned from studying different human and animal influenza viruses. Specifically, reconstruction of the genes of the 1918 pandemic virus and studies on their contribution to virulence will be important steps toward understanding the biological capabilities of this lethal virus. Increasing the availability of new antiviral drugs and developing superior vaccines will provide us with better approaches to control influenza and to have a positive impact on disease load. A concern is that the imposition of new rules for working with infectious influenza viruses under high security and high containment conditions will stifle scientific progress. The complex questions of what makes an influenza virus transmissible from one human to another and from one species to another, as well as how the immune system interacts with the virus, will require the active collaboration and unencumbered work of many scientific groups.
Similar articles
-
Influenza: lessons from past pandemics, warnings from current incidents.Nat Rev Microbiol. 2005 Aug;3(8):591-600. doi: 10.1038/nrmicro1208. Nat Rev Microbiol. 2005. PMID: 16064053 Review.
-
Vaccines to protect humans from pandemic avian influenza strains.Md Med. 2006 Winter;7(1):15-8. Md Med. 2006. PMID: 16613361 Review.
-
Seasonal and pandemic influenza: a 2007 update on challenges and solutions.Clin Infect Dis. 2008 Apr 1;46(7):1024-31. doi: 10.1086/528720. Clin Infect Dis. 2008. PMID: 18444819 Review.
-
Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Expert Rev Vaccines. 2007 Apr;6(2):193-201. doi: 10.1586/14760584.6.2.193. Expert Rev Vaccines. 2007. PMID: 17408369 Review.
-
Avian influenza pandemic threat and health systems response.Emerg Med Australas. 2006 Oct-Dec;18(5-6):430-43. doi: 10.1111/j.1742-6723.2006.00906.x. Emerg Med Australas. 2006. PMID: 17083631 Review.
Cited by
-
A review of vaccine research and development: human acute respiratory infections.Vaccine. 2005 Dec 30;23(50):5708-24. doi: 10.1016/j.vaccine.2005.07.046. Epub 2005 Aug 3. Vaccine. 2005. PMID: 16154667 Free PMC article. Review.
-
Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan's unique ecosystems against influenza viruses and paramyxoviruses.Virol J. 2019 Dec 2;16(1):150. doi: 10.1186/s12985-019-1254-1. Virol J. 2019. PMID: 31791359 Free PMC article.
-
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model.PLoS One. 2010 Apr 21;5(4):e10266. doi: 10.1371/journal.pone.0010266. PLoS One. 2010. PMID: 20422002 Free PMC article.
-
Antiviral agents active against influenza A viruses.Nat Rev Drug Discov. 2006 Dec;5(12):1015-25. doi: 10.1038/nrd2175. Nat Rev Drug Discov. 2006. PMID: 17139286 Free PMC article. Review.
-
Adaptation of a diverse simian immunodeficiency virus population to a new host is revealed through a systematic approach to identify amino acid sites under selection.Mol Biol Evol. 2007 Mar;24(3):660-9. doi: 10.1093/molbev/msl194. Epub 2006 Dec 11. Mol Biol Evol. 2007. PMID: 17159231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical